Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 199.07

-3.4%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: bluejeans who wrote (15545)	2/20/1998 6:54:00 PM
From: Henry Niman	Read Replies (2) of 32384

I agree that the LLY option is very topical. I have to look at the filing again, but isn't the deadline next week? I strongly suspect that the drug in question is SRGN's IL-2 DAB (diptheria toxin) which has been approved for FDA review for treating CTCL. The alternative is $20 million is cash (for stock at a 20% premium, as well as an additional 1 1/2% royalty on the rexinoid of LGND's choice). What did you see in the filing?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next